Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
DOI: 10.1007/3-540-26420-5_15
|View full text |Cite
|
Sign up to set email alerts
|

Use of Dynamic Contrast-Enhanced MRI in Multi-Centre Trials with Particular Reference to Breast Cancer Screening in Women at Genetic Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…While it has become widely recognized that MRI offers unique information on the extent of disease, staging and recurrence, it is still too expensive to be practical as a screening tool for the general population. However, a number of groups are exploring the use of MRI in the screening of high-risk women who present with mutations in the BRCA1 or BRCA2 genes or an extensive family history of breast cancer (Leach 1998, Kuhl et al 1999, Stoutjesdijk et al 1999. This small group of women represents an ideal population for screening by MRI as it is only 0.1-0.2% of the general population, yet is responsible for 5-10% of all breast cancer (Ford et al 1994).…”
Section: Introductionmentioning
confidence: 99%
“…While it has become widely recognized that MRI offers unique information on the extent of disease, staging and recurrence, it is still too expensive to be practical as a screening tool for the general population. However, a number of groups are exploring the use of MRI in the screening of high-risk women who present with mutations in the BRCA1 or BRCA2 genes or an extensive family history of breast cancer (Leach 1998, Kuhl et al 1999, Stoutjesdijk et al 1999. This small group of women represents an ideal population for screening by MRI as it is only 0.1-0.2% of the general population, yet is responsible for 5-10% of all breast cancer (Ford et al 1994).…”
Section: Introductionmentioning
confidence: 99%